symbol,statement_type,period_end,line_item,value
KREBSBIO.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.3
KREBSBIO.NS,income,2025-03-31 00:00:00,Normalized EBITDA,-143206000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Total Unusual Items,0.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,-269393000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,66892000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,55557000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,EBITDA,-143206000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,EBIT,-210098000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Net Interest Income,-59142000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Interest Expense,59142000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Interest Income,
KREBSBIO.NS,income,2025-03-31 00:00:00,Normalized Income,-269393000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,-269393000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Total Expenses,650308000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
KREBSBIO.NS,income,2025-03-31 00:00:00,Diluted Average Shares,
KREBSBIO.NS,income,2025-03-31 00:00:00,Basic Average Shares,
KREBSBIO.NS,income,2025-03-31 00:00:00,Diluted EPS,
KREBSBIO.NS,income,2025-03-31 00:00:00,Basic EPS,
KREBSBIO.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,-269393000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,-269393000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Net Income,-269393000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,-269393000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Net Income Discontinuous Operations,
KREBSBIO.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,-269393000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Tax Provision,153000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Pretax Income,-269240000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,7089000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Special Income Charges,0.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Other Special Charges,
KREBSBIO.NS,income,2025-03-31 00:00:00,Write Off,
KREBSBIO.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-59142000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Total Other Finance Cost,
KREBSBIO.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,59142000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
KREBSBIO.NS,income,2025-03-31 00:00:00,Operating Income,-217189000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Operating Expense,594751000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Other Operating Expenses,361875000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,66892000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Amortization,
KREBSBIO.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,66892000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Selling General And Administration,
KREBSBIO.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,
KREBSBIO.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
KREBSBIO.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
KREBSBIO.NS,income,2025-03-31 00:00:00,Gross Profit,377562000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Cost Of Revenue,55557000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Total Revenue,433119000.0
KREBSBIO.NS,income,2025-03-31 00:00:00,Operating Revenue,433119000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Normalized EBITDA,-82727000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Total Unusual Items,0.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,-197284000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,67663000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,65873000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,EBITDA,-82727000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,EBIT,-150390000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Net Interest Income,-46894000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Interest Expense,46894000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Interest Income,1567000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Normalized Income,-197284000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,-197284000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Total Expenses,659118000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,5788000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Diluted Average Shares,21561093.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Basic Average Shares,21561093.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Diluted EPS,-9.15
KREBSBIO.NS,income,2024-03-31 00:00:00,Basic EPS,-9.15
KREBSBIO.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,-197284000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,-197284000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Net Income,-197284000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,-197284000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Net Income Discontinuous Operations,
KREBSBIO.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,-197284000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Tax Provision,0.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Pretax Income,-197284000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,4513000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Special Income Charges,0.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Other Special Charges,
KREBSBIO.NS,income,2024-03-31 00:00:00,Write Off,
KREBSBIO.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-46894000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Total Other Finance Cost,35000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,46894000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,1567000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Operating Income,-154903000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Operating Expense,593245000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Other Operating Expenses,360841000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,67663000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Amortization,1838000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,67663000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Selling General And Administration,6001000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,
KREBSBIO.NS,income,2024-03-31 00:00:00,General And Administrative Expense,6001000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,5788000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Gross Profit,438342000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Cost Of Revenue,65873000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Total Revenue,504215000.0
KREBSBIO.NS,income,2024-03-31 00:00:00,Operating Revenue,504215000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Normalized EBITDA,-151624000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Total Unusual Items,0.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,-246919000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,65585000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,423518000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,EBITDA,-151624000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,EBIT,-217209000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Net Interest Income,-27529000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Interest Expense,29710000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Interest Income,2203000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Normalized Income,-246919000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,-246919000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Total Expenses,740735000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,6879000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Diluted Average Shares,21560586.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Basic Average Shares,21560586.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Diluted EPS,-11.3
KREBSBIO.NS,income,2023-03-31 00:00:00,Basic EPS,-11.3
KREBSBIO.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,-246919000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,-246919000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Net Income,-246919000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,-246919000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Net Income Discontinuous Operations,
KREBSBIO.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,-246919000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Tax Provision,0.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Pretax Income,-246919000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,6201000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Special Income Charges,0.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Other Special Charges,
KREBSBIO.NS,income,2023-03-31 00:00:00,Write Off,
KREBSBIO.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,-27529000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Total Other Finance Cost,22000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,29710000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,2203000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Operating Income,-219391000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Operating Expense,317217000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Other Operating Expenses,48810000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,65585000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Amortization,1839000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,63746000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Selling General And Administration,8598000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,
KREBSBIO.NS,income,2023-03-31 00:00:00,General And Administrative Expense,8598000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,6879000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Gross Profit,97826000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Cost Of Revenue,423518000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Total Revenue,521344000.0
KREBSBIO.NS,income,2023-03-31 00:00:00,Operating Revenue,521344000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Normalized EBITDA,-328456000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Total Unusual Items,0.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,-445268000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,62966000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,654674000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,EBITDA,-328456000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,EBIT,-391422000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Net Interest Income,-50332000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Interest Expense,53846000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Interest Income,3578000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Normalized Income,-445268000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,-445268000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Total Expenses,991966000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,6807000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Diluted Average Shares,21560586.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Basic Average Shares,21560586.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Diluted EPS,-20.81
KREBSBIO.NS,income,2022-03-31 00:00:00,Basic EPS,-20.81
KREBSBIO.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,-445268000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,-445268000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Net Income,-445268000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,-445268000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Net Income Discontinuous Operations,0.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,-445268000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Tax Provision,0.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Pretax Income,-445268000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,10169000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Special Income Charges,0.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Other Special Charges,1791000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Write Off,0.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,-50332000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Total Other Finance Cost,64000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,53846000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,3578000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Operating Income,-394935000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Operating Expense,337292000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Other Operating Expenses,74703000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,62966000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Amortization,6386000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,56580000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Selling General And Administration,11384000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,38000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,General And Administrative Expense,11384000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,6807000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Gross Profit,-57643000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Cost Of Revenue,654674000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Total Revenue,597031000.0
KREBSBIO.NS,income,2022-03-31 00:00:00,Operating Revenue,597031000.0
KREBSBIO.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
KREBSBIO.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
KREBSBIO.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
KREBSBIO.NS,income,2021-03-31 00:00:00,Total Unusual Items,
KREBSBIO.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
KREBSBIO.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
KREBSBIO.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
KREBSBIO.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
KREBSBIO.NS,income,2021-03-31 00:00:00,EBITDA,
KREBSBIO.NS,income,2021-03-31 00:00:00,EBIT,
KREBSBIO.NS,income,2021-03-31 00:00:00,Net Interest Income,
KREBSBIO.NS,income,2021-03-31 00:00:00,Interest Expense,
KREBSBIO.NS,income,2021-03-31 00:00:00,Interest Income,721000.0
KREBSBIO.NS,income,2021-03-31 00:00:00,Normalized Income,
KREBSBIO.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
KREBSBIO.NS,income,2021-03-31 00:00:00,Total Expenses,
KREBSBIO.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,9425000.0
KREBSBIO.NS,income,2021-03-31 00:00:00,Diluted Average Shares,19620586.0
KREBSBIO.NS,income,2021-03-31 00:00:00,Basic Average Shares,19620586.0
KREBSBIO.NS,income,2021-03-31 00:00:00,Diluted EPS,-14.453493
KREBSBIO.NS,income,2021-03-31 00:00:00,Basic EPS,-14.453493
KREBSBIO.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
KREBSBIO.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
KREBSBIO.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
KREBSBIO.NS,income,2021-03-31 00:00:00,Net Income,
KREBSBIO.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
KREBSBIO.NS,income,2021-03-31 00:00:00,Net Income Discontinuous Operations,0.0
KREBSBIO.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
KREBSBIO.NS,income,2021-03-31 00:00:00,Tax Provision,
KREBSBIO.NS,income,2021-03-31 00:00:00,Pretax Income,
KREBSBIO.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
KREBSBIO.NS,income,2021-03-31 00:00:00,Special Income Charges,
KREBSBIO.NS,income,2021-03-31 00:00:00,Other Special Charges,465000.0
KREBSBIO.NS,income,2021-03-31 00:00:00,Write Off,802000.0
KREBSBIO.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
KREBSBIO.NS,income,2021-03-31 00:00:00,Total Other Finance Cost,73000.0
KREBSBIO.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
KREBSBIO.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,721000.0
KREBSBIO.NS,income,2021-03-31 00:00:00,Operating Income,
KREBSBIO.NS,income,2021-03-31 00:00:00,Operating Expense,
KREBSBIO.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
KREBSBIO.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
KREBSBIO.NS,income,2021-03-31 00:00:00,Amortization,2602000.0
KREBSBIO.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
KREBSBIO.NS,income,2021-03-31 00:00:00,Selling General And Administration,6762000.0
KREBSBIO.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,47000.0
KREBSBIO.NS,income,2021-03-31 00:00:00,General And Administrative Expense,6715000.0
KREBSBIO.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,3065000.0
KREBSBIO.NS,income,2021-03-31 00:00:00,Gross Profit,
KREBSBIO.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
KREBSBIO.NS,income,2021-03-31 00:00:00,Total Revenue,
KREBSBIO.NS,income,2021-03-31 00:00:00,Operating Revenue,
